SAN DIEGO, Aug. 15, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable again through its Branded Compounding(TM) business model, today reported the expansion of its ... 4 Traders, 1 month ago
Imprimis Strengthens Senior Leadership Team With Key Hires In Operations, Quality, Manufacturing And Client Relations - BioSpace, 1 month ago
2 images for "Qualitest Pharmaceuticals"
Imprimis Pharmaceuticals Adds to Senior Leadership Team with Hires in Operations, Quality, Manufacturing and Client Relations
Imprimis Pharmaceuticals has reported the expansion of its leadership team with the appointments ofClayton Edwardsas Senior Vice President of Operations,Eric Riceas Vice President of Client Relations,Pramod Sharma, PhD as Vice President of Quality, ...American Pharmaceutical Review, 1 month ago
Actinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams
Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it has added two industry ...International Business Times, 2 weeks ago ACTINIUM PHARMACEUTICALS : Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams 4 Traders, 2 weeks ago
ALJ MaryJoan McNamara issued Order No. 5 in Certain Potassium Chloride Powder Products (Inv. No. 337-TA-1013). By way of background, this investigation is based on a complaint filed by Lehigh Valley Technologies, Inc., Endo Global Ventures, ...Lexology, 2 weeks ago ITC Institutes Investigation (337-TA-1013) Regarding Certain Potassium Chloride Powder Products Lexology, 1 month ago Certain Potassium Chloride Powder Products; Institution of Investigation Federal Register, 2 months ago Potassium Chloride Powder Products United States International Trade Commission, 2 months ago
Propranolol oral tablet, Global 10 mg, 1000 count (NDC 50111-0467-03) 80 mg, 500 count (NDC 50111-0471-02) Propranolol oral tablet, Major 10 mg, unit-dose 100 count (NDC 00904-0411-61) - discontinued Reason for the Shortage Actavis has ...ASHP, 2 weeks ago
We have received so many complaints about generic Ambien that we have lost count. We notified the FDA years ago about this problem but so far there seems to be no interest in finding out what the problems are. Here are some readers who are ...Peoples Pharmacy, 1 month ago
Endo International Plc (NASDAQ: ENDP ) Q2 2016 Earnings Call August 08, 2016 4:30 pm ET Executives Keri P. Mattox - Senior Vice President, Investor Relations & Corporate Affairs Rajiv De Silva - President, Chief Executive Officer & ...Seeking Alpha, 1 month ago Endo Reports Second Quarter 2016 Financial Results Minyanville, 1 month ago Endo International plc ( ENDP ) Stock Junction, 1 month ago Earnings in Focus: Endo International plc (NASDAQ:ENDP) Markets Daily, 2 months ago
Introduction Endo International (NASDAQ: ENDP ) is a hybrid generic and branded drug company with a roughly 60/40 revenue split between generic and branded pharmaceuticals. Both businesses have various challenges but in the current negative ...Seeking Alpha, 1 month ago Weitz Funds Comments on Endo International Yahoo! Finance, 2 months ago
By VW Staff Weitz Value Fund commentary for the second quarter ended June 30, 2016. The Weitz Value Fund's Institutional Class returned -0.41% in the second calendar quarter, compared to +2.46% for the S&P 500 and +2.54% for the Russell 1000.Seeking Alpha, 1 month ago Weitz Value Fund 2Q16 Commentary: Hurt By Liberty Global, Endo, Allergan News EasyBranches.com, 1 month ago
- By Holly LaFon The Value Fund's Institutional Class returned -0.41% in the second calendar quarter, compared to +2.46% for the S&P 500 and +2.54% for the Russell 1000. For the calendar year to date, the Value Fund's Institutional Class ...Yahoo! Finance, 2 months ago Weitz Funds' —nd Quarter —…6 Value Fund Commentary Guru Focus, 2 months ago
on your WebpageAdd Widget >Get your members hooked!